Xiaojing Cheng

1.9k total citations · 1 hit paper
57 papers, 1.3k citations indexed

About

Xiaojing Cheng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaojing Cheng has authored 57 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 19 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Xiaojing Cheng's work include Gastric Cancer Management and Outcomes (9 papers), Cancer-related molecular mechanisms research (8 papers) and RNA modifications and cancer (8 papers). Xiaojing Cheng is often cited by papers focused on Gastric Cancer Management and Outcomes (9 papers), Cancer-related molecular mechanisms research (8 papers) and RNA modifications and cancer (8 papers). Xiaojing Cheng collaborates with scholars based in China, Ethiopia and United States. Xiaojing Cheng's co-authors include Jiafu Ji, Hong Du, Ting Guo, Xiaofang Xing, Xianzi Wen, Lianhai Zhang, Ziyu Li, Ying Hu, Xiaohong Wang and Xueyi Li and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Xiaojing Cheng

56 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1‐Foxo1 and PI3K‐Akt signalling pathways

2020 232 citations Bincheng Ren, Xiaojing Cheng et al. Journal of Cellular and Molecular Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaojing Cheng China	19	690	352	312	211	179	57	1.3k
Armel Hervé Nwabo Kamdje Cameroon	19	685 1.0×	349 1.0×	268 0.9×	144 0.7×	160 0.9×	46	1.4k
Masayuki Nagahashi Japan	14	503 0.7×	394 1.1×	287 0.9×	178 0.8×	155 0.9×	27	1.0k
Antônio Palumbo Brazil	21	676 1.0×	277 0.8×	285 0.9×	195 0.9×	265 1.5×	47	1.4k
Deqiang Wang China	18	506 0.7×	325 0.9×	374 1.2×	320 1.5×	136 0.8×	94	1.1k
Ken‐ichi Kozaki Japan	21	906 1.3×	312 0.9×	357 1.1×	178 0.8×	134 0.7×	34	1.5k
Chao Liang China	20	724 1.0×	336 1.0×	345 1.1×	151 0.7×	140 0.8×	53	1.3k
Shu‐Biao Wu China	23	841 1.2×	294 0.8×	457 1.5×	131 0.6×	146 0.8×	55	1.2k
Guo‐Hui Fu China	22	801 1.2×	298 0.8×	443 1.4×	128 0.6×	122 0.7×	64	1.4k
Patricia Castro United States	18	559 0.8×	274 0.8×	210 0.7×	283 1.3×	165 0.9×	44	1.1k
Wenting Xu China	18	872 1.3×	424 1.2×	412 1.3×	206 1.0×	168 0.9×	46	1.6k

Countries citing papers authored by Xiaojing Cheng

Since Specialization

Citations

This map shows the geographic impact of Xiaojing Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Cheng more than expected).

Fields of papers citing papers by Xiaojing Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojing Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Cheng. The network helps show where Xiaojing Cheng may publish in the future.

Co-authorship network of co-authors of Xiaojing Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojing Cheng. A scholar is included among the top collaborators of Xiaojing Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojing Cheng. Xiaojing Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Xiaojing, Xuejing Huang, Donghai Wen, et al.. (2025). pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation. Cell Death Discovery. 11(1). 11–11. 7 indexed citations

Cheng, Xiaojing, Yongning Jia, Xiaohuan Tang, et al.. (2024). ABCC2 induces metabolic vulnerability and cellular ferroptosis via enhanced glutathione efflux in gastric cancer. Clinical and Translational Medicine. 14(8). e1754–e1754. 12 indexed citations

Shen, Li, Yiding Wang, Hong Du, et al.. (2023). Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer. International Journal of Molecular Sciences. 24(6). 5482–5482. 5 indexed citations

Han, Jing, Cong Chen, Xiaojing Cheng, et al.. (2022). SDCBP‐AS1 destabilizes β‐catenin by regulating ubiquitination and SUMOylation of hnRNP K to suppress gastric tumorigenicity and metastasis. Cancer Communications. 42(11). 1141–1161. 13 indexed citations

Xing, Xiaofang, Jinyao Shi, Yongning Jia, et al.. (2022). Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis. Journal for ImmunoTherapy of Cancer. 10(3). e003984–e003984. 40 indexed citations

Guo, Ting, Yanhua Bai, Xiaojing Cheng, et al.. (2021). Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4. Cancer Communications. 41(3). 258–272. 28 indexed citations

Han, Jing, Cong Chen, Xiaojing Cheng, et al.. (2021). CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways. International Journal of Biological Sciences. 17(11). 2841–2852. 18 indexed citations

Tian, Yuan, Xiaojing Cheng, Zhaojun Liu, et al.. (2021). CDKN2A Deletion Leading to Hematogenous Metastasis of Human Gastric Carcinoma. Frontiers in Oncology. 11. 801219–801219. 14 indexed citations

Huangfu, Longtao, Jing Han, Xiaomei Li, et al.. (2021). MicroRNA-135b/CAMK2D Axis Contribute to Malignant Progression of Gastric Cancer through EMT Process Remodeling. International Journal of Biological Sciences. 17(8). 1940–1952. 17 indexed citations

10.

Ren, Bincheng, Xiaojing Cheng, Xin Yang, et al.. (2020). Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1‐Foxo1 and PI3K‐Akt signalling pathways. Journal of Cellular and Molecular Medicine. 24(21). 12355–12367. 232 indexed citations breakdown →

11.

Li, Xiaomei, Xiaojing Cheng, Longtao Huangfu, et al.. (2020). TNFRSF11B activates Wnt/β-catenin signaling and promotes gastric cancer progression. International Journal of Biological Sciences. 16(11). 1956–1971. 32 indexed citations

12.

Cui, Can, Xiaojing Cheng, Yan Liang, et al.. (2019). <p>Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway</p>. Cancer Management and Research. Volume 11. 6323–6341. 40 indexed citations

13.

Xing, Xiaofang, Bin Dong, Xiaojing Cheng, et al.. (2018). Higher autocrine motility factor/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer. Cancer Management and Research. Volume 10. 4969–4980. 19 indexed citations

14.

Li, Lin, Xiaojing Cheng, Zhixue Zheng, et al.. (2016). Overexpression of cancer cell-derived immunoglobulin G correlates with poor prognosis in gastric cancer patients. Translational Cancer Research. 5(3). 285–293. 3 indexed citations

15.

Yuan, Peng, Xiaojing Cheng, Xiaojiang Wu, et al.. (2016). OSMR and SEPT9: promising biomarkers for detection of colorectal cancer based on blood-based tests. Translational Cancer Research. 5(2). 131–139. 5 indexed citations

16.

Wang, Xiaohong, Hong Du, Li Lin, et al.. (2016). Increased expression of S100A6 promotes cell proliferation in gastric cancer cells. Oncology Letters. 13(1). 222–230. 24 indexed citations

17.

Cheng, Xiaojing, et al.. (2014). Losartan Inhibits Nuclear Factor-κB Activation Induced by Small, Dense LDL Cholesterol Particles in Human Umbilical Vein Endothelial Cells. Current Therapeutic Research. 76. 17–20. 3 indexed citations

18.

Du, Yunxia, Lianhai Zhang, Xiaojing Cheng, et al.. (2012). 03. Expression of CEBPB in human gastric carcinoma and its clinical significance. 2 indexed citations

19.

Fan, Biao, Lianhai Zhang, Yongning Jia, et al.. (2012). Presence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer. BMC Cancer. 12(1). 316–316. 29 indexed citations

20.

Cheng, Xiaojing, et al.. (2007). Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers. Annals of Oncology. 19(3). 527–532. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact